Cargando…
MKX-AS1 Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients
Oxaliplatin (OXAL) is a commonly used chemotherapy for treating colorectal cancer (CRC). A recent genome wide association study (GWAS) showed that a genetic variant (rs11006706) in the lncRNA gene MKX-AS1 and partnered sense gene MKX could impact the response of genetically varied cell lines to OXAL...
Autores principales: | Gonzalez, Ricardo D., Small, George W., Green, Adrian J., Akhtari, Farida S., Motsinger-Reif, Alison A., Quintanilha, Julia C. F., Havener, Tammy M., Reif, David M., McLeod, Howard L., Wiltshire, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222429/ https://www.ncbi.nlm.nih.gov/pubmed/37242540 http://dx.doi.org/10.3390/ph16050757 |
Ejemplares similares
-
RYK Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients
por: Gonzalez, Ricardo D., et al.
Publicado: (2023) -
Pharmacogenomic Analyses Implicate B Cell Developmental Status and MKL1 as Determinants of Sensitivity toward Anti-CD20 Monoclonal Antibody Therapy
por: Small, George W., et al.
Publicado: (2023) -
The influence of Neanderthal alleles on cytotoxic response
por: Akhtari, Farida S., et al.
Publicado: (2018) -
High-throughput screening and genome-wide analyses of 44 anticancer drugs in the 1000 Genomes cell lines reveals an association of the NQO1 gene with the response of multiple anticancer drugs
por: Akhtari, Farida S., et al.
Publicado: (2021) -
Synergistic Chemotherapy Drug Response Is a Genetic Trait in Lymphoblastoid Cell Lines
por: Roell, Kyle R., et al.
Publicado: (2019)